| Stage | CHRW | % of rev | HUBG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.4B | 100.00% | $934M | 100.00% | CHRW ×5.73 |
| Gross profit | $448M | 8.36% | $791M | 84.69% | HUBG +76.3pp |
| Operating income | $272M | 5.07% | $39M | 4.22% | CHRW +0.9pp |
| Pre-tax income | $250M | 4.67% | $39M | 4.12% | CHRW +0.5pp |
| Net income | $198M | 3.70% | $29M | 3.10% | CHRW +0.6pp |
| Stage | CHRW | HUBG | Gap · A − B |
|---|---|---|---|
| Revenue | $5.4B100.00% | $934M100.00% | CHRW ×5.73 |
| Gross profit | 8.36%$448M | 84.69%$791M | HUBG +76.3pp |
| Operating income | 5.07%$272M | 4.22%$39M | CHRW +0.9pp |
| Pre-tax income | 4.67%$250M | 4.12%$39M | CHRW +0.5pp |
| Net income |
| 3.70%$198M |
| 3.10%$29M |
| CHRW +0.6pp |
None
No disclosed counterparties: CHRW.